NKX6.1 hypermethylation predicts the outcome of stage II colorectal cancer patients undergoing chemotherapy-Reference-Cited by-全球学者库

NKX6.1 hypermethylation predicts the outcome of stage II colorectal cancer patients undergoing chemotherapy

Published:2018-02-10 Issue:5 Volume:57 Page:268-277
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Chang Sou-Yi¹²,Kuo Chih-Chi³,Wu Chang-Chieh⁴,Hsiao Cheng-Wen⁴,Hu Je-Ming¹⁴,Hsu Chih-Hsiung¹⁵,Chou Yu-Ching⁶,Shih Yu-Lueng¹⁷,Lin Ya-Wen¹⁸⁹^ORCID

Affiliation:

1. Graduate Institute of Medical Sciences, National Defense Medical Center; Taipei Taiwan Republic of China

2. Division of Hematology & Oncology, Department of Internal Medicine; Taipei Tzu Chi Hospital; Taipei Taiwan Republic of China

3. Teaching and Research Office, Tri-Service General Hospital Songshan Branch, National Defense Medical Center; Taipei Taiwan Republic of China

4. Division of Colorectal Surgery, Department of Surgery; Tri-Service General Hospital, National Defense Medical Center; Taipei Taiwan Republic of China

5. School of Medicine; National Defense Medical Center; Taipei Taiwan Republic of China

6. School of Public Health; National Defense Medical Center; Taipei Taiwan Republic of China

7. Division of Gastroenterology, Department of Internal Medicine; Tri-Service General Hospital, National Defense Medical Center; Taipei Taiwan Republic of China

8. Graduate Institute of Life Sciences, National Defense Medical Center; Taipei Taiwan Republic of China

9. Department and Graduate Institute of Microbiology and Immunology; National Defense Medical Center; Taipei Taiwan Republic of China

Funder

The Ministry of Science and Technology, Taiwan, Republic of China

Ministry of National Defense, People's Republic of China

The Liver Disease Prevention and Treatment Research Foundation, Taiwan, Republic of China

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference62 articles.

1. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015;Collaborators GBDRF;Lancet.,2016

2. Colorectal cancer;Brenner;Lancet.,2014

3. Postoperative adjuvant chemotherapy for stage II colorectal cancer: a systematic review of 12 randomized controlled trials;Wu;J Gastrointest Surg.,2012

4. A review of the evolution of systemic chemotherapy in the management of colorectal cancer;Gustavsson;Clin Colorectal Cancer.,2015

5. Adjuvant therapy trials;Ursem;Cancer J.,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromatin factors: Ready to roll as biomarkers in metastatic colorectal cancer?;Pharmacological Research;2023-10

2. Epigenetic and Genetics Factors;Molecular Targets and Cancer Therapeutics (Part 1);2023-04-18

3. SOX1 Functions as a Tumor Suppressor by Repressing HES1 in Lung Cancer;Cancers;2023-04-08

4. Epigenome-Wide DNA Methylation Profiling in Colorectal Cancer and Normal Adjacent Colon Using Infinium Human Methylation 450K;Diagnostics;2022-01-14

5. NKX6-1 mediates cancer stem-like properties and regulates sonic hedgehog signaling in leiomyosarcoma;Journal of Biomedical Science;2021-04-27